Evolent Health, Inc.
EVH · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $1.88B | $2.55B | −26.6% |
| Operating income | −$410M | −$40.5M | −913% |
| Net income | −$579M | −$93.5M | −520% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $725M | $480M | +51.3% |
| Operating income | −$6.20M | $900K | |
| Net income | −$23.6M | −$26.9M | +12.3% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Evolent Health's revenue in FY2025?
- $1.88B in FY2025 (Fiscal year ended Dec 31, 2025), −26.6% vs $2.55B a year earlier, per its 10-K filed Feb 2026.
- Was Evolent Health profitable in FY2025?
- No: net income was −$579M and operating income −$410M in FY2025.
- What was Evolent Health's revenue in Q3 2026?
- $725M (+51.3% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.